Ki Park, MD
Interventional Cardiology · Dallas, TXNPI 1902994700
Payments from drug & device makers
Across 111 payments — averaging $340.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$19K
- Cardiovascular Systems Inc.$12K
- Edwards Lifesciences$4K
- Boston Scientific$635
- Medtronic$558
- ZOLL Circulation Inc$441
- plus $1K from 5 others
What the payments were for
- Consulting fees$12,18032%
- Speaking & faculty fees$14,17538%
- Travel & lodging$5,01413%
- Food & beverage$6,42917%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 46 | $18,518 |
| Cardiovascular Systems Inc. | 10 | $12,454 |
| Edwards Lifesciences | 28 | $4,067 |
| Boston Scientific | 5 | $635 |
| Medtronic(2 entities) | 8 | $558 |
| ZOLL Circulation Inc | 4 | $441 |
| Shockwave Medical, Inc | 3 | $408 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $279 |
| AstraZeneca | 2 | $227 |
| Irhythm Technologies, Inc. | 1 | $175 |
| Abiomed | 1 | $38 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Diamondback Coronary$16,917
- Xience Sierra Coronary Stent$5,000
- XIENCE SIERRA$2,750
- Xience V coronary stent system$1,477
- EVOQUE$1,349
- SAPIEN 3 Ultra RESILIA$1,270
- Diamondback Peripheral$810
- TRICLIP$762
- Dragonfly OCT$750
- SUPERA$750
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$298
- TherOx DS2 Console$287
- Catheter$287
- Downstream Cartridge$287
- 3F$273
- Edwards SAPIEN 3 Transcatheter Heart Valve$236
- Optis Coronary Imaging System$222
- ZIO Patch$175
- DRAGONFLY OPSTAR$173
- Ultreon$163
How this compares
$37,798 in reported general payments places this provider in the 75th percentile of 686 interventional cardiology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Dallas
- Robert StolerDallas$8.2M
- James ChoiDallas$5.2M
- Cara Ann EastDallas$3M
- Byung ParkDallas$735K
- Anthony BavryDallas$359K
- Donald WurzburgDallas$341K
- Tony DasDallas$263K
- Zachary RosolDallas$257K
- Srinivasa PotluriPlano$5.1M
- Neal KleimanHouston$4.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.